Hydroquinone-induced exogenous ochronosis: A report of four cases and usefulness of dermoscopy

International Journal of Dermatology

Volumn 47, Issue 1, 2008, Pages 19-23

  Charlín, Raúl ^a,b   Barcaui, Carlos B ^a   Kac, Bernard Kawa ^a   Soares, Deborah Brazuna ^a   Rabello fonseca, Rosa ^a   Azulay abulafia, Luna ^a  

^a Instituto de Dermatologia Prof Rubem David Azulay   (Brazil)

^b NONE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; DIPYRONE; HYDROQUINONE; KOJIC ACID; MELANI D; RETINOIC ACID; UNCLASSIFIED DRUG;

ADULT; APPLICATION SITE HYPERPIGMENTATION; ARTICLE; CASE REPORT; CHLOASMA; DEPIGMENTATION; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EPILUMINESCENCE MICROSCOPY; EXOGENOUS OCHRONOSIS; FEMALE; HUMAN; HUMAN TISSUE; NEODYMIUM LASER; OCHRONOSIS; SKIN BIOPSY; SKIN PIGMENTATION; SKIN STRUCTURE;

ADMINISTRATION, CUTANEOUS; ADULT; DERMATOLOGIC AGENTS; DERMOSCOPY; FEMALE; HUMANS; HYDROQUINONES; HYPERPIGMENTATION; HYPOPIGMENTATION; MELANOSIS; MIDDLE AGED; OCHRONOSIS; SKIN;

EID: 37449004162     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03351.x     Document Type: Article

References (37)

1. Virchow R. Ein Fall von allegemeiner ochronose der knorpel aud knorpelahnlichen theile. Virchows Arch (Pathol Anat) 1866; 37.
2. Fisher AA. Exogenous ochronosis from hydroquinone bleaching cream. Cutis 1998; 62: 11-12.
3. La Du BN. Alkaptonuria. In: Scriver CR, Beaudet A, Sly W, et al. eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 2001, p. 1371.
4. Van Offel JF, DeClerck LS, Francx LM, et al. The clinical manifestations of ochronosis: A review. Acta Clin Belg 1995; 50: 358-362.
5. Goldsmith LA. Cutaneous changes in errors of amino acid metabolism: alkaptonuria. In: Fitzpatrick, TB, Eisen, AZ, Wolff, K, et al. eds. Dermatology in General Medicine, Chapter 48. New York: McGraw-Hill, 1993, pp. 1841-1845.
6. Beddard AP, Plumtre CM. A further note on ochronosis associated with carboluria. Q S Med 1912; 5: 505-507.
7. Berry JL, Peat S. Ochronosis: Report of a case with carboluria. Lancet 1931; 2: 124-126.
8. Brogren N. Case of exogenetic ochronosis from carbolic acid compresses. Acta Derm Venereol (Stockholm) 1952; 32: 258-260.
9. Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol 1975; 93: 613-622.
10. Sugar HS, Waddell WW. Ochronosis-like pigmentation associated with the use of atabrine. Ill Med J 1946; 89: 234-239.
11. Ludwig GD, Toole JF, Wood JC. Ochronosis from quinacrine (atabrine). Ann Intern Med 1963; 59: 378-384.
12. Tuffanelli D, Abraham RK, Dubois EI. Pigmentation from antimalarial therapy. Its possible relationship to the ocular lesions. Arch Dermatol 1963; 88: 419-426.
13. Egorin MJ, Trump DL, Wainwright CW. Quinacrine ochronosis and rheumatoid arthritis. JAMA 1976; 236: 385-386.
14. Cullison D, Abele DC, O'Quinn JL. Localized exogenous ochronosis. J Am Acad Dermatol 1983 June; 8: 882-889.
15. 2 laser. J Dermatol Surg Oncol 1990; 16: 1018-1022.
16. Fitzpatrick TB. Soleil et peau. J Med Esthet 1975; 2: 33.
17. Hoshaw RA, Zimmerman KG, Menter A. Ochronosis-like pigmentation from hydroquinone bleaching creams in Americans blacks. Arch Dermatol 1985; 121: 105-108.
18. Penneys NS. Ochronosis-like pigmentation from bleaching creams. Arch Dermatol 1985; 121: 1239-1240.
19. O'Donoghue MN, Lynfield YL, Derbes V. Ochronosis due to hydroquinone. J Am Acad Dermatol 1983; 8: 123.
20. Jordaan HF, Van Niekerk DJ. Transepidermal elimination in exogenous ochronosis. A report of two cases. Am J Dermatopathol; 13: 418-424.
21. Kramer KE, Lopez A, Stefanato CM, et al. Exogenous ochronosis. J Am Acad Dermatol 2000; 42 (5 Part 2): 869-871.
22. Bellew SG, Alster TS. Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser. Dermatol Surg 2004; 30 (4 Part 1): 555-558.
23. Dogliotte M, Leibowitz M. Granulomatous ochronosis - a cosmetic- induced skin disorder in blacks. S Afr Med J 1979; 56: 757-760.
24. Sanchez NP, Pathak MA, Sato S, et al. Melasma: A clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698-710.
25. Kang WH, Yoon KH, Lee ES, et al. Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol; 2002; 146: 228-237.
26. Grimes PE, Yamada N, Bhawan J. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol 2005; 27: 96-101.
27. Victor FC, Gelber J, Rao B. Melasma: A review. J Cutan Med Surg 2004; 8: 97-102.
28. Connor T, Braunstein B. Hyperpigmentation following the use of bleaching creams. Localized exogenous ochronosis. Arch Dermatol 1987; 123: 105-6, 108.
29. Howard K, Furner B. Exogenous ochronosis in a Mexican-American woman. Cutis 1990; 45: 180-182.
30. Schutz E, Summers B, Summers R. Inappropriate treatment of cosmetic ochronosis with hydroquinone. S Afr Med J 1988; 73: 59-60.
31. Snider RL, Thiers BH. Exogenous ochronosis. J Am Acad Dermatol 1993; 28: 662-664.
32. Lang PG. Probable coexisting exogenous ochronosis and mercurial pigmentation managed by dermabrasion. J Am Acad Dermatol 1988; 19: 942-946.
33. Taylor CR, Gange RW, Dover JS et al. Treatment of tattoos by Q-switched ruby laser: A dose-response study. Arch Dermatol 1990; 126: 893-899.
34. Hruza GJ, Dover JS, Flotte TJ et al. Q-switched ruby laser irradiation of normal human skin. Arch Dermatol 1991; 127: 1799-1805.
35. Jacyk WK. Annular granulomatous lesions in exogenous ochronosis are manifestation of sarcoidosis. Am J Dermatopathol 1995; 17: 18-22.
36. Stolz W. Color Atlas of Dermoscopy, 2nd edn. Berlin: Blackwell Wissenschafts-Verlag G 2002, pp. 121-131.
37. Jeghers H. Pigmentation of the skin. N Engl J Med 1944; 231: 88-100.